1887

Abstract

Introduction. Lyme borreliosis is a multisystem tick-borne disease caused by Borrelia burgdo rferi. Neurological manifestations are reported in up to 15 % of adult patients with Lyme disease, while the frequency among children is higher. The most common manifestations are painful radiculopathy, facial nerve paresis and lymphocytic meningitis. Epileptic seizures and cerebral vasculitis with stroke or aneurysms are very rare complications.

Case presentation. We describe a paediatric patient with sensorineural auditory dysfunction, headache, fatigue and epileptic seizures as sequelae of meningoencephalitis/Lyme neuroborreliosis (LNB) caused by B. burgdo rferi. Brain magnetic resonance imaging revealed widespread enhancement of the leptomeninges, cranial nerves and artery walls compatible with vasculitis and disturbances in cerebrospinal fluid (CSF) circulation. The patient was treated with ceftriaxone for 2 weeks. Two years later, the patient had an ischemic stroke. Brain magnetic resonance angiography revealed multiple aneurysms, which were not present previously. The largest aneurysm was operated rapidly. The patient was treated with another course of intravenous ceftriaxone for 4 weeks and pulse therapy with corticosteroids. He recovered well.

Conclusion

. This unique case demonstrates complications of LNB that can result in serious morbidity or even mortality. Lumbar puncture and analysis should be considered for paediatric patients with epileptic seizures or cerebrovascular events living in a Lyme borreliosis endemic area.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005090
2017-04-21
2019-10-16
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/4/4/jmmcr005090.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005090&mimeType=html&fmt=ahah

References

  1. Back T, Grünig S, Winter Y, Bodechtel U, Guthke K et al. Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life. J Neurol 2013;260:1569–1575 [CrossRef][PubMed]
    [Google Scholar]
  2. Topakian R, Stieglbauer K, Nussbaumer K, Aichner FT. Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledge. Cerebrovasc Dis 2008;26:455–461 [CrossRef][PubMed]
    [Google Scholar]
  3. Salvarani C, Brown RD, Hunder GG. Adult primary central nervous system vasculitis. Lancet 2012;380:767–777 [CrossRef][PubMed]
    [Google Scholar]
  4. Wittwer B, Pelletier S, Ducrocq X, Maillard L, Mione G et al. Cerebrovascular events in Lyme neuroborreliosis. J Stroke Cerebrovasc Dis 2015;24:1671–1678 [CrossRef][PubMed]
    [Google Scholar]
  5. Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis - epidemiology, diagnosis and management. Nat Rev Neurol 2015;11:446–456 [CrossRef][PubMed]
    [Google Scholar]
  6. van Burgel ND, Bakels F, Kroes AC, van Dam AP. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid. J Clin Microbiol 2011;49:2027–2030 [CrossRef][PubMed]
    [Google Scholar]
  7. Hytönen J, Kortela E, Waris M, Puustinen J, Salo J et al. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. J Neuroinflammation 2014;11:103 [CrossRef][PubMed]
    [Google Scholar]
  8. Oksi J, Kalimo H, Marttila RJ, Marjamäki M, Sonninen P et al. Intracranial aneurysms in three patients with disseminated Lyme borreliosis: cause or chance association?. J Neurol Neurosurg Psychiatry 1998;64:636–642 [CrossRef][PubMed]
    [Google Scholar]
  9. Oksi J, Kalimo H, Marttila RJ, Marjamäki M, Sonninen P et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996;119:2143–2154[PubMed][CrossRef]
    [Google Scholar]
  10. Tugwell P, Dennis DT, Weinstein A, Wells G, Shea B et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997;127:1109–1123 [CrossRef][PubMed]
    [Google Scholar]
  11. Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD, Philipp MT et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003;187:1187–1199 [CrossRef][PubMed]
    [Google Scholar]
  12. CDC Lyme disease – United States, 2003–2005. MMWR Morb Mortal Wkly Rep 2007;56:573–576[PubMed]
    [Google Scholar]
  13. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringér A et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995;333:1319–1327 [CrossRef][PubMed]
    [Google Scholar]
  14. Henningsson AJ, Malmvall BE, Ernerudh J, Matussek A, Forsberg P. Neuroborreliosis – an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden. Clin Microbiol Infect 2010;16:1245–1251 [CrossRef][PubMed]
    [Google Scholar]
  15. Tveitnes D, Natås OB, Skadberg Ø, Øymar K. Lyme meningitis, the major cause of childhood meningitis in an endemic area: a population based study. Arch Dis Child 2012;97:215–220 [CrossRef][PubMed]
    [Google Scholar]
  16. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011;17:69–79 [CrossRef][PubMed]
    [Google Scholar]
  17. Zajkowska J, Czupryna P, Kuśmierczyk J, Ciemerych A, Ciemerych M et al. [Clinical forms of neuroborreliosis – the analysis of patients diagnosed in department of infectious diseases and neuroinfection medical academy in Bialystok between 2000-2005]. Przegl Epidemiol 2007;61:59–65[PubMed]
    [Google Scholar]
  18. Seijo Martínez M, Grandes Ibáñez J, Sánchez Herrero J, García-Moncó JC. Spontaneous brain hemorrhage associated with Lyme neuroborreliosis. Neurologia 2001;16:43–45[PubMed]
    [Google Scholar]
  19. Scheid R, Hund-Georgiadis M, von Cramon DY. Intracerebral haemorrhage as a manifestation of Lyme neuroborreliosis?. Eur J Neurol 2003;10:99–101 [CrossRef][PubMed]
    [Google Scholar]
  20. Mallick AA, Ganesan V, Kirkham FJ, Fallon P, Hedderly T et al. Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study. Lancet Neurol 2014;13:35–43 [CrossRef][PubMed]
    [Google Scholar]
  21. Mackay MT, Wiznitzer M, Benedict SL, Lee KJ, Deveber GA et al. Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol 2011;69:130–140 [CrossRef][PubMed]
    [Google Scholar]
  22. Mineyko A, Kirton A. Mechanisms of pediatric cerebral arteriopathy: an inflammatory debate. Pediatr Neurol 2013;48:14–23 [CrossRef][PubMed]
    [Google Scholar]
  23. Nagel MA. Varicella zoster virus vasculopathy: clinical features and pathogenesis. J Neurovirol 2014;20:157–163 [CrossRef][PubMed]
    [Google Scholar]
  24. Sébire G, Meyer L, Chabrier S. Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann Neurol 1999;45:679–680 [CrossRef][PubMed]
    [Google Scholar]
  25. Askalan R, Laughlin S, Mayank S, Chan A, MacGregor D et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001;32:1257–1262[PubMed][CrossRef]
    [Google Scholar]
  26. Shah SS, Zimmerman RA, Rorke LB, Vezina LG. Cerebrovascular complications of HIV in children. AJNR Am J Neuroradiol 1996;17:1913–1917[PubMed]
    [Google Scholar]
  27. Guidi B, Bergonzini P, Crisi G, Frigieri G, Portolani M. Case of stroke in a 7-year-old male after parvovirus B19 infection. Pediatr Neurol 2003;28:69–71 [CrossRef][PubMed]
    [Google Scholar]
  28. Bell ML, Buchhalter JR. Influenza A-associated stroke in a 4-year-old male. Pediatr Neurol 2004;31:56–58 [CrossRef][PubMed]
    [Google Scholar]
  29. Ribai P, Liesnard C, Rodesch G, Giurgea S, Verheulpen D et al. Transient cerebral arteriopathy in infancy associated with enteroviral infection. Eur J Paediatr Neurol 2003;7:73–75 [CrossRef][PubMed]
    [Google Scholar]
  30. Ovetchkine P, Brugières P, Seradj A, Reinert P, Cohen R. An 8-y-old boy with acute stroke and radiological signs of cerebral vasculitis after recent Mycoplasma pneumoniae infection. Scand J Infect Dis 2002;34:307–309 [CrossRef][PubMed]
    [Google Scholar]
  31. Hinterseher I, Gäbel G, Corvinus F, Lück C, Saeger HD et al. Presence of Borrelia burgdorferi sensu lato antibodies in the serum of patients with abdominal aortic aneurysms. Eur J Clin Microbiol Infect Dis 2012;31:781–789 [CrossRef][PubMed]
    [Google Scholar]
  32. Cuisset T, Hamilos M, Vanderheyden M. Coronary aneurysm in Lyme disease: treatment by covered stent. Int J Cardiol 2008;128:e72e73 [CrossRef][PubMed]
    [Google Scholar]
  33. Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999;12:187–209[PubMed]
    [Google Scholar]
  34. Jackman JD, Radolf JD. Cardiovascular syphilis. Am J Med 1989;87:425–433 [CrossRef][PubMed]
    [Google Scholar]
  35. Miklossy J. Chronic or late Lyme neuroborreliosis: analysis of evidence compared to chronic or late neurosyphilis. Open Neurol J 2012;6:146–157 [CrossRef][PubMed]
    [Google Scholar]
  36. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011;10:626–636 [CrossRef][PubMed]
    [Google Scholar]
  37. Thompson BG, Brown RD, Amin-Hanjani S, Broderick JP, Cockroft KM et al. Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2015;46:2368–2400 [CrossRef][PubMed]
    [Google Scholar]
  38. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M et al. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013;35:93–112 [CrossRef][PubMed]
    [Google Scholar]
  39. Wiebers DO, Piepgras DG, Meyer FB, Kallmes DF, Meissner I et al. Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms. Mayo Clin Proc 2004;79:1572–1583 [CrossRef][PubMed]
    [Google Scholar]
  40. Matsubara S, Hadeishi H, Suzuki A, Yasui N, Nishimura H. Incidence and risk factors for the growth of unruptured cerebral aneurysms: observation using serial computerized tomography angiography. J Neurosurg 2004;101:908–914 [CrossRef][PubMed]
    [Google Scholar]
  41. Miyazawa N, Akiyama I, Yamagata Z. Risk factors for growth of unruptured intracranial aneurysms: follow-up study by serial 0.5-T magnetic resonance angiography. Neurosurgery 2006;58:1047–1053 [CrossRef][PubMed]
    [Google Scholar]
  42. Juvela S, Porras M, Heiskanen O. Natural history of unruptured intracranial aneurysms: a long-term follow-up study. J Neurosurg 1993;79:174–182 [CrossRef][PubMed]
    [Google Scholar]
  43. Patterson JM, Eberly LE, Ding Y, Hargreaves M. Associations of smoking prevalence with individual and area level social cohesion. J Epidemiol Community Health 2004;58:692–697 [CrossRef][PubMed]
    [Google Scholar]
  44. Lindgren AE, Kurki MI, Riihinen A, Koivisto T, Ronkainen A et al. Hypertension predisposes to the formation of saccular intracranial aneurysms in 467 unruptured and 1053 ruptured patients in Eastern Finland. Ann Med 2014;46:169–176 [CrossRef][PubMed]
    [Google Scholar]
  45. Iero I, Elia M, Cosentino FI, Lanuzza B, Spada RS et al. Isolated monolateral neurosensory hearing loss as a rare sign of neuroborreliosis. Neurol Sci 2004;25:30–33 [CrossRef][PubMed]
    [Google Scholar]
  46. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B et al. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 2005;65:448–450 [CrossRef][PubMed]
    [Google Scholar]
  47. Ljøstad U, Mygland A. CSF Blymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 2008;255:732–737 [CrossRef][PubMed]
    [Google Scholar]
  48. Schmidt C, Plate A, Angele B, Pfister HW, Wick M et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011;76:1051–1058 [CrossRef][PubMed]
    [Google Scholar]
  49. Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis 2010;37:283–287 [CrossRef][PubMed]
    [Google Scholar]
  50. Wang C, Wu K, Yu Q, Zhang S, Gao Z et al. CXCL13, CXCL10 and CXCL8 as potential biomarkers for the diagnosis of neurosyphilis patients. Sci Rep 2016;6:33569 [CrossRef][PubMed]
    [Google Scholar]
  51. Fischer L, Korfel A, Pfeiffer S, Kiewe P, Volk HD et al. CXCL13 and CXCL12 in central nervous system lymphoma patients. Clin Cancer Res 2009;15:5968–5973 [CrossRef][PubMed]
    [Google Scholar]
  52. Rubenstein JL, Wong VS, Kadoch C, Gao HX, Barajas R et al. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood 2013;121:4740–4748 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005090
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005090
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error